NDC properties for NDC 9 55513-400
NDC item 55513040001
| NDC 9 | 55513-400 |
|---|---|
| NDC 10 | 55513-400-01 |
| NDC Item | 55513040001 |
| packaging | 1 SYRINGE in 1 CARTON (55513-400-01) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 807577 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-01-31 |
| Marketing status | ACTIVE |
NDC item 55513040002
| NDC 9 | 55513-400 |
|---|---|
| NDC 10 | 55513-400-02 |
| NDC Item | 55513040002 |
| packaging | 2 SYRINGE in 1 CARTON (55513-400-02) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 807577 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-01-31 |
| Marketing status | ACTIVE |
NDC item 55513040091
| NDC 9 | 55513-400 |
|---|---|
| NDC 10 | 55513-400-91 |
| NDC Item | 55513040091 |
| packaging | 1 SYRINGE in 1 CARTON (55513-400-91) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 807577 |
| Labeler | Amgen Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-01-31 |
| Marketing status | ACTIVE |
NDC item 72511040001
| NDC 9 | 72511-400 |
|---|---|
| NDC 10 | 72511-400-01 |
| NDC Item | 72511040001 |
| packaging | 1 SYRINGE in 1 CARTON (72511-400-01) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 828840 |
| Labeler | Amgen USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-01-31 |
| Marketing status | ACTIVE |
NDC item 72511040002
| NDC 9 | 72511-400 |
|---|---|
| NDC 10 | 72511-400-02 |
| NDC Item | 72511040002 |
| packaging | 2 SYRINGE in 1 CARTON (72511-400-02) / .8 mL in 1 SYRINGE |
| BLA | BLA761024 |
| FDA SPL set id | 828840 |
| Labeler | Amgen USA Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-01-31 |
| Marketing status | ACTIVE |